References:
1. Suchonwanit P, Leerunyakul K, Kositkuljorn C. Cutaneous manifestations in COVID-19: lessons learned from current evidence. Journal of the American Academy of Dermatology. 2020;83(1):e57.
2. Mohseni Afshar Z, Babazadeh A, Hasanpour A, Barary M, Sayad B, Janbakhsh A, et al. Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge. Journal of medical virology. 2021;93(10):5756-67.
3. Panambur B, Kakkilaya SB. Palmar erythema as the sole manifestation of COVID-19. Cureus. 2020;12(11).
4. Rodriguez-Cerdeira C, Uribe-Camacho BI, Silverio-Carrasco L, Méndez W, Mahesh AR, Tejada A, et al. Cutaneous manifestations in COVID-19: report on 31 cases from five countries. Biology. 2021;10(1):54.
5. Miladi R, Janbakhsh A, Babazadeh A, Aryanian Z, Ebrahimpour S, Barary M, et al. Pustular psoriasis flare‐up in a patient with COVID‐19. Journal of Cosmetic Dermatology. 2021;20(11):3364-8.
6. Novak N, Peng W, Naegeli MC, Galvan C, Kolm‐Djamei I, Brüggen C, et al. SARS‐CoV‐2, COVID‐19, skin and immunology–What do we know so far? Allergy. 2021;76(3):698-713.
7. Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L. Cutaneous manifestations of SARS‐CoV‐2 infection: a clinical update. Journal of the European Academy of Dermatology and Venereology. 2020;34(11):2499-504.
8. Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JB, Naldi L, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR). British Journal of Dermatology. 2007;157(5):989-96.
9. Hoegler K, John A, Handler M, Schwartz R. Generalized pustular psoriasis: a review and update on treatment. Journal of the European Academy of Dermatology and Venereology. 2018;32(10):1645-51.
10. Mashayekhi F, Seirafianpour F, Pour Mohammad A, Goodarzi A. Severe and life‐threatening COVID‐19‐related mucocutaneous eruptions: A systematic review. International Journal of Clinical Practice. 2021;75(12):e14720.
11. Ghosn J, Duvivier C, Tubiana R, Katlama C, Caumes E. Acute generalized exanthematous pustulosis induced by HIV postexposure prophylaxis with lopinavir-ritonavir. Clinical infectious diseases. 2005;41(9):1360-1.
12. De Coninck A, Van Strubarq A, Pipeleers-Marichal M, Huyghens L, Suys E, Roseeuw D. Acute generalized exanthematous pustulosis induced by paracetamol. Dermatology. 1996;193(4):338-41.
13. Vettorazzi J, Valério EG, Kayser ML, Pezzali LG, Vettori DV, Rostirolla GF. Acute generalized exanthematous pustulosis during puerperal period induced by azithromycin: case report. Open Journal of Obstetrics and Gynecology Irvine vol 8, no 11 (2018), p 1156-1162. 2018.
14. Delaleu J, Deniau B, Battistella M, de Masson A, Bensaid B, Jachiet M, et al. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19. The Journal of Allergy and Clinical Immunology: In Practice. 2020;8(8):2777-9. e1.
15. Bailey K, Mckee D, Wismer J, Shear N. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature. 2013.
16. Buettiker U, Keller M, Pichler WJ, Braathen LR, Yawalkar N. Oral prednisolone induced acute generalized exanthematous pustulosis due to corticosteroids of group A confirmed by epicutaneous testing and lymphocyte transformation tests. Dermatology. 2006;213(1):40-3.
17. Atak MF, Farabi B, Akbayrak A, Kalelioğlu MB, Rao BK. Acute Generalized Exanthematous Pustulosis Following Treatment with Favipiravir in A Patient with COVID‐19 without Hydroxychloroquine Use: Report of The First Case. Journal of Cosmetic Dermatology. 2021.
18. Yates J, Choudhry M, Keys G. A case report describing a suspected rivaroxaban hypersensitivity reaction in a surgical patient. Journal of clinical pharmacy and therapeutics. 2013;38(2):159-61.
19. Daye M, Oltulu P. An AGEP case due to COVİD-19 or favipiravir or enoxaparin. Journal of cosmetic dermatology. 2022;21(1):13-5.
20. Ingen-Housz-Oro S, Hotz C, Valeyrie-Allanore L, Sbidian E, Hemery F, Chosidow O, et al. Acute generalized exanthematous pustulosis: a retrospective audit of practice between 1994 and 2011 at a single centre. The British journal of dermatology. 2015;172(5):1455-7.
21. Lee HY, Chou D, Pang SM, Thirumoorthy T. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore. International journal of dermatology. 2010;49(5):507-12.
22. Hadavand MA, Kaffenberger B, Cartron AM, Trinidad JC. Clinical Presentation and Management of Atypical and Recalcitrant Acute Generalized Exanthematous Pustulosis (AGEP). Journal of the American Academy of Dermatology. 2020.
23. Nikyar Z, Hatami P, Aryanian Z, Kamyab Hesari K, Goodarzi A, Borzouei A. Coexistence of Neonatal Lupus Erythematous and Sturge-Weber Syndrome. Case Rep Dermatol Med. 2021 Dec 30;2021:3616429. doi: 10.1155/2021/3616429. PMID: 35003813; PMCID: PMC8736701.
24. Mohaghegh F, Hatami P, Saber M, Heidari A, Zolfaghari A, Rezaee M, Aryanian Z. Unusual presentations of cutaneous leishmaniasis: pearls for correct diagnosis. Int J Dermatol. 2022 Jan 4. doi: 10.1111/ijd.16035. Epub ahead of print. PMID: 34982471.
25. Akhyani M, Hatami P, Yadegarfar Z, Ghanadan A. Pigmented colloid milium associated with exogenous ochronosis in a farmer with long-term exposure to fertilizers. J Dermatol Case Rep. 2015 Jun 30;9(2):42-5. doi: 10.3315/jdcr.2015.1197. PMID: 26236412; PMCID: PMC4517802.
26. Kalantari Y, Sadeghzadeh-Bazargan A, Aryanian Z, Hatami P, Goodarzi A. The first reported case of delayed-type hypersensitivity reaction to Non-hyaluronic acid Polycaprolactone dermal filler following COVID-19 vaccination: A case report and a review of the literature. Clin. Case Rep.2022. Doi: 10.1002/ccr3.5343
27. Mohaghegh F, Hatami P, Aryanian Z. A case of atypical disseminated herpes zoster in a patient with COVID-19; a diagnostic challenge in COVID era. J Clinical Case Reports. 2022. Doi: 10.1002/ccr3.5342
28. Torkashvand F, Rezaeian M, Sheikh Fathollahi M, Mohammadreza Khaninezhad S, Hatami P, Bidaki R. A Survey on Psychiatric Disorders in Patients Improved Cutaneous Leishmaniasis In the city of Rafsanjan in 2014. JRUMS. 2016; 14 (10) :879-894. URL: http://journal.rums.ac.ir/article-1-2344-en.html